Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarkko Rautio

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Molecular Pharmaceutics|April 23, 2020
Prodrug Approach for Posterior Eye Drug Delivery: Synthesis of Novel Ganciclovir Prodrugs and in Vitro Screening with Cassette DosingEmma M Heikkinen, Marika Ruponen, Lisa-Marie Jasper, et al.
Molecular Cancer Therapeutics|October 30, 2014
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowthYulian P Ramirez, Ann C Mladek, Roger M Phillips, et al.
Molecular Pharmaceutics|May 3, 2023
Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture TherapyJelena Matović, Katayun Bahrami, Philipp Stockmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substratesJarkko Rautio, Joan E Humphreys, Lindsey O Webster, et al.
Chemmedchem|September 11, 2014
Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1)Henna Ylikangas, Kalle Malmioja, Lauri Peura, et al.
Bioorganic & Medicinal Chemistry|September 21, 2016
Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835Mikhail Krasavin, Alexey Lukin, Daria Bagnyukova, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2023
Specific transport of temozolomide does not override DNA repair-mediated chemoresistanceKatayun Bahrami, Jussi Kärkkäinen, Sania Bibi, et al.
ACS Omega|September 5, 2022
Synthesis and <i>In Vitro</i> Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 TransporterJelena Matović, Juulia Järvinen, Iris K Sokka, et al.
ACS Omega|December 11, 2023
Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of <i>trans</i>-Cyclooctene-Functionalized Molecular Spherical Nucleic AcidsTatsiana Auchynnikava, Antti Äärelä, Heidi Liljenbäck, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture TherapyMichele Retini, Juulia Järvinen, Katayun Bahrami, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Molecular Pharmaceutics|April 23, 2020
Prodrug Approach for Posterior Eye Drug Delivery: Synthesis of Novel Ganciclovir Prodrugs and in Vitro Screening with Cassette DosingEmma M Heikkinen, Marika Ruponen, Lisa-Marie Jasper, et al.
Molecular Cancer Therapeutics|October 30, 2014
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowthYulian P Ramirez, Ann C Mladek, Roger M Phillips, et al.
Molecular Pharmaceutics|May 3, 2023
Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture TherapyJelena Matović, Katayun Bahrami, Philipp Stockmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substratesJarkko Rautio, Joan E Humphreys, Lindsey O Webster, et al.
Chemmedchem|September 11, 2014
Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1)Henna Ylikangas, Kalle Malmioja, Lauri Peura, et al.
Bioorganic & Medicinal Chemistry|September 21, 2016
Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835Mikhail Krasavin, Alexey Lukin, Daria Bagnyukova, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2023
Specific transport of temozolomide does not override DNA repair-mediated chemoresistanceKatayun Bahrami, Jussi Kärkkäinen, Sania Bibi, et al.
ACS Omega|September 5, 2022
Synthesis and <i>In Vitro</i> Evaluation of a Set of 6-Deoxy-6-thio-carboranyl d-Glucoconjugates Shed Light on the Substrate Specificity of the GLUT1 TransporterJelena Matović, Juulia Järvinen, Iris K Sokka, et al.
ACS Omega|December 11, 2023
Tetrazine Glycoconjugate for Pretargeted Positron Emission Tomography Imaging of <i>trans</i>-Cyclooctene-Functionalized Molecular Spherical Nucleic AcidsTatsiana Auchynnikava, Antti Äärelä, Heidi Liljenbäck, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture TherapyMichele Retini, Juulia Järvinen, Katayun Bahrami, et al.
Pageof 9